Literature DB >> 17996929

Augmented epithelial endothelin-1 expression in refractory asthma.

Sophie Pégorier1, Nassim Arouche, Marie-Christine Dombret, Michel Aubier, Marina Pretolani.   

Abstract

BACKGROUND: Airway remodeling in patients with severe steroid-refractory asthma might result from a reduced ability of steroid therapy to limit the transcription of remodeling factors by the bronchial epithelium.
OBJECTIVE: We sought to compare the levels of transcripts encoding remodeling factors in bronchial epithelium of healthy volunteers and of asthmatic patients with either steroid-sensitive or steroid-refractory disease and to correlate these levels with hallmarks of airway remodeling.
METHODS: By means of real-time quantitative PCR, we assessed the levels of 14 transcripts encoding remodeling factors, matrix metalloproteinases, and extracellular matrix proteins in laser-capture microdissected bronchial epithelium of healthy volunteers, patients with mild steroid-untreated asthma, and patients with steroid-sensitive and steroid-refractory asthma (n = 8-10 in each group). Histologic features of airway remodeling and endothelin-1 (EDN1) immunolocalization were determined by using frozen specimens.
RESULTS: Patients with steroid-refractory asthma had greater levels of EDN1 transcripts (4.1-fold increase, P = .026) and protein (P = .0009) in their bronchial epithelium compared with patients with steroid-sensitive asthma. EDN1 mRNA levels and protein expression in asthmatic patients were negatively correlated with prebronchodilator and postbronchodilator FEV(1) value (r(2) >or= 0.193, P <or= .03), and they were positively related to airway smooth muscle areas (r(2) = 0.253, P = .01 and r(2) = 0.281, P = .005 for EDN1 mRNA and protein expression, respectively).
CONCLUSION: Increased EDN1 synthesis by the bronchial epithelium characterizes severe refractory asthma and correlates with airway remodeling and airflow obstruction. CLINICAL IMPLICATIONS: Targeting EDN1 might represent a novel therapeutic strategy for severe steroid-refractory asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996929     DOI: 10.1016/j.jaci.2007.09.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

1.  Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system.

Authors:  A S Ahmedat; M Warnken; W K Seemann; K Mohr; E Kostenis; U R Juergens; K Racké
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 2.  Endothelin-1 gene regulation.

Authors:  Lisa R Stow; Mollie E Jacobs; Charles S Wingo; Brian D Cain
Journal:  FASEB J       Date:  2010-09-13       Impact factor: 5.191

3.  Novel small airway bronchodilator responses to rosiglitazone in mouse lung slices.

Authors:  Jane E Bourke; Yan Bai; Chantal Donovan; James G Esposito; Xiahui Tan; Michael J Sanderson
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

4.  Expression analysis of asthma candidate genes during human and murine lung development.

Authors:  Erik Melén; Alvin T Kho; Sunita Sharma; Roger Gaedigk; J Steven Leeder; Thomas J Mariani; Vincent J Carey; Scott T Weiss; Kelan G Tantisira
Journal:  Respir Res       Date:  2011-06-23

Review 5.  Emerging therapies for severe asthma.

Authors:  Neil C Thomson; Rekha Chaudhuri; Mark Spears
Journal:  BMC Med       Date:  2011-09-06       Impact factor: 8.775

6.  Endothelin-1 directs airway remodeling and hyper-reactivity in a murine asthma model.

Authors:  L G Gregory; C P Jones; S A Mathie; S Pegorier; C M Lloyd
Journal:  Allergy       Date:  2013-10-14       Impact factor: 13.146

7.  Epigenetics of hyper-responsiveness to allergen challenge following intrauterine growth retardation rat.

Authors:  Xue-Feng Xu; Qiong-Yao Hu; Ling-Fang Liang; Lei Wu; Wei-Zhong Gu; Li-Li Tang; Lin-Chen Fu; Li-Zhong Du
Journal:  Respir Res       Date:  2014-11-13

8.  Endothelin-1 mediates Aspergillus fumigatus-induced airway inflammation and remodelling.

Authors:  Briony Labram; Sara Namvar; Tracy Hussell; Sarah E Herrick
Journal:  Clin Exp Allergy       Date:  2019-03-18       Impact factor: 5.018

Review 9.  Novel Neuropathic Pain Mechanisms Associated With Allergic Inflammation.

Authors:  Takayuki Fujii; Ryo Yamasaki; Jun-Ichi Kira
Journal:  Front Neurol       Date:  2019-12-17       Impact factor: 4.003

10.  The impact of allergic rhinitis and asthma on human nasal and bronchial epithelial gene expression.

Authors:  Ariane H Wagener; Aeilko H Zwinderman; Silvia Luiten; Wytske J Fokkens; Elisabeth H Bel; Peter J Sterk; Cornelis M van Drunen
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.